Literature DB >> 29670686

ATR Inhibitors as Potential Treatment for Cancers.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2018        PMID: 29670686      PMCID: PMC5900326          DOI: 10.1021/acsmedchemlett.8b00107

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Targeting ATR in cancer medicine.

Authors:  Raghav Sundar; Jessica Brown; Alvaro Ingles Russo; Timothy A Yap
Journal:  Curr Probl Cancer       Date:  2017-05-17       Impact factor: 3.187

Review 2.  The development of ataxia telangiectasia mutated kinase inhibitors.

Authors:  Martin Andrs; Jan Korabecny; Eugenie Nepovimova; Daniel Jun; Zdenek Hodny; Simona Moravcova; Hana Hanzlikova; Kamil Kuca
Journal:  Mini Rev Med Chem       Date:  2014       Impact factor: 3.862

Review 3.  Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy.

Authors:  Martin Andrs; Jan Korabecny; Eugenie Nepovimova; Daniel Jun; Zdenek Hodny; Kamil Kuca
Journal:  Curr Cancer Drug Targets       Date:  2016       Impact factor: 3.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.